Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News Editorials & Other Articles General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

General Discussion

Showing Original Post only (View all)

BlueWaveNeverEnd

(15,699 posts)
Thu Jul 9, 2026, 03:26 PM Thursday

Proposed rule could gut American science, Penn researcher warns [View all]

https://www.inquirer.com/opinion/commentary/neuroscience-research-funding-dementia-genetics--20260709.html


The Trump administration is seeking not only to cut research funding, but to give political appointees veto power over how and what kinds of scientific study are permissible.

On May 29, the White House’s Office of Management and Budget (OMB)published a 100-page proposed rule that would fundamentally restructure how the federal government administers research grants. The comment period closes July 13.

Most Americans have never heard of it. That needs to change.

The rule has several alarming impacts. For instance, it would allow political appointees to override scientific peer review in grant decisions, upending the meritocratic, rigorous system that has pushed American science forward since World War II.
Perhaps most critically, it would permit the government to terminate any active federal grant at any time, for any reason — including the vague, undefined justification that a study is no longer in the “national interest.”

Furthermore, it would effectively ban federal funding for research into health disparities across racial populations, with a stated exception so narrow it is meaningless in practice.

------

The ban on research into racial disparities will compound this harm. Black Americans are diagnosed with Alzheimer’s at roughly twice the rate of white Americans
. Population differences in disease risk, progression, and biomarkers are not ideological claims, but instead are observed, replicated findings in the scientific literature.

3 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Latest Discussions»General Discussion»Proposed rule could gut A...